Heru
Heru Inc. (www.SeeHeru.com) has developed patented autonomous AI-powered vision diagnostics and augmentation software for use on commercially available AR/VR devices. This technology exceeds traditional standards of care in clinical equivalence, usability, cost, size, and portability. Heru is the only cross-platform solution that can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s unique vision defects. Heru originated as a spinout from Bascom Palmer Eye Institute. In December 2020, Heru announced FDA registration and a seed round led by Fred Drasner, Maurice R. Ferre, M.D., Fred H. Moll, M.D., and a consortium of investors with extensive experience developing, launching, and scaling cutting-edge medical technologies.
Domain
seeheru.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
51-100
Last Funding
$30.0M
Founded
2017
Tech Stack (36 technologies)
Frequently Asked Questions
What technologies does Heru use?+
Heru uses 36 technologies including Elementor, Facebook Pixel, Google Analytics.
What industry is Heru in?+
Heru operates in the Artificial Intelligence (AI) industry.
Where is Heru based?+
Heru is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026